Multiple predicted and inferred targets

Multiple predicted and inferred targets is a non-specific classification used in pharmacological databases, such as ChEMBL, to describe a situation where a compound's activity is linked to a broad set of potential molecular entities rather than a single, well-defined target (Gaulton et al., 2012). This designation often arises from phenotypic screening results or computational in silico predictions where the specific binding partners have not been experimentally confirmed (Mendez et al., 2019). It does not represent a unique protein, enzyme, or receptor, but rather serves as a placeholder for complex or undefined polypharmacology. Consequently, it lacks the specific biological functions, molecular classifications, and disease roles typically associated with validated therapeutic targets. For biotech analysts, this label indicates a significant level of uncertainty regarding the drug's precise molecular mechanism and suggests a higher risk of off-target effects. The use of this term highlights the challenges in mapping small molecule activity to specific genomic products when the underlying biology is multi-faceted or poorly understood. Because it is an aggregate category, it cannot be used for targeted therapy design or precision medicine in the same way a specific kinase or G protein-coupled receptor would be utilized.

Unknown or polypharmacological